(Source: BioScrip Inc) ELMSFORD, N.Y., June 17, 2013/PRNewswire/ -- BioScrip®, Inc. (NASDAQ: BIOS) ("BioScrip") previously announced that it had commenced a cash tender offer (the "Tender Offer") and consent solicitation (the "Consent Solicitation," and together with the Tender Offer, the "Offer") for any and all of its $225 millionaggregate principal amount of 10¼% Senior Notes due 2015 (CUSIP No. 09069NAC2) (the "Notes"). The Offer is described in the Offer to Purchase and Consent Solicitation Statement dated June 3, 2013(the "Offer to Purchase"). In connection with BioScrip's recently disclosed acquisition of...
↧